Where can I buy FSD Pharma shares?
Shares of FSDDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is FSD Pharma's stock price today?
When does FSD Pharma report its next quarterly earnings?
FSD Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 15th 2022. View our earnings forecast for FSD Pharma. Who are FSD Pharma's key executives?
What happened at FSD Pharma's AGM?
TORONTO, June 27, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today the results of its annual general meeting of shareholders ("AGM"), held online and in virtual-only format on June 23, 2022.
Is FSD Pharma a good buy?
FSD Pharma Inc (NASDAQ:HUGE) The 1 analysts offering 12-month price forecasts for FSD Pharma Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +921.35% increase from the last price of 0.98.
What is going on with FSD Pharma?
The facility became non-essential to FSD Pharma after it decided in early 2020 to exit the cannabis production market to focus on the biotech market, advancing novel drug candidates targeting lucrative areas of unmet medical needs like Muscular Sclerosis, Depression Disorders, and Inflammatory Disorders.
FSD Pharma Announces Launch of New Corporate Website
FSD Pharma Congratulates Dr. Eleanor Fish on Being Named to the Order of Canada
TORONTO, January 20, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today the launch of its newly designed website.
FSD Pharma to Present at the H.C. Wainwright Bioconnect Conference on January 10-13th
TORONTO, January 18, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, warmly congratulates Eleanor N.
What is FSD Pharma?
TORONTO, January 04, 2022--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that Anthony Durkacz, Interim CEO of FSD Pharma, will present at the H.C.
Who is the founder of FSD Pharma?
FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") wishes to alert you to the events that have occurred since the Company filed its Management Information Circular (the "Circular") and the accompanying letter to shareholders related to the Annual & Special Meeting of shareholders scheduled for May 14, 2021, copies of which are available under the Company's SEDAR profile. On April 26, 2021, certain dissident shareholders issued an information circular which included misleading statements and baseless accusations towards the Company's management. In response, the Company issued the following letter to shareholders:
What is FSD Pharma?
On Tuesday, March 30, 2021, Anthony Durkacz, a founding director and member of the group of concerned shareholders, which also includes founding shareholder Zeeshan Saeed, (the "Concerned Shareholders") of FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9) (the "Company" or "FSD") received a Notice of Appeal from FSD (the "Appeal") of the March 5, 2021 decision (the "Decision") of the Ontario Superior Court of Justice (Commercial List) (the "Court"). The Decision, which resulted from an application to the Court brought by Mr. Durkacz on behalf of the Concerned Shareholders, ordered the Company to accelerate the date of its previously called annual shareholders' meeting (the "Meeting") from June 29, 2021 to May 14, 2021, retain an independent chair to preside over the Meeting and prevent Dr. Raza Bokhari and other directors from voting recently issued shares (the "Order").
Who is the founder of FSD Pharma?
FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") wishes to alert you to the events that have occurred since the Company filed its Management Information Circular (the "Circular") and the accompanying letter to shareholders related to the Annual & Special Meeting of shareholders scheduled for May 14, 2021, copies of which are available under the Company's SEDAR profile. On April 26, 2021, certain dissident shareholders issued an information circular which included misleading statements and baseless accusations towards the Company's management. In response, the Company issued the following letter to shareholders:
About FSD Pharma
On Tuesday, March 30, 2021, Anthony Durkacz, a founding director and member of the group of concerned shareholders, which also includes founding shareholder Zeeshan Saeed, (the "Concerned Shareholders") of FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9) (the "Company" or "FSD") received a Notice of Appeal from FSD (the "Appeal") of the March 5, 2021 decision (the "Decision") of the Ontario Superior Court of Justice (Commercial List) (the "Court"). The Decision, which resulted from an application to the Court brought by Mr. Durkacz on behalf of the Concerned Shareholders, ordered the Company to accelerate the date of its previously called annual shareholders' meeting (the "Meeting") from June 29, 2021 to May 14, 2021, retain an independent chair to preside over the Meeting and prevent Dr. Raza Bokhari and other directors from voting recently issued shares (the "Order").
FSD Pharma (NYSE:HUGE) Frequently Asked Questions
FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company.
About FSD Pharma
FSD Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 15th 2022. View our earnings forecast for FSD Pharma.
How has FSD Pharma's stock price been impacted by COVID-19 (Coronavirus)?
FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company.
Who are some of FSD Pharma's key competitors?
FSD Pharma's stock was trading at $4.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, FSDDF stock has decreased by 80.2% and is now trading at $0.84. View which stocks have been most impacted by COVID-19.
How do I buy shares of FSD Pharma?
Some companies that are related to FSD Pharma include Acreage (ACRZF), Core One Labs (CLABD), Costa Group (CTTQF), Feel Foods (FLLLF), First Resources Ltd. (Singapore) (FTROF), IOI Corp. Bhd.
What is FSD Pharma's stock price today?
Shares of FSDDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
How much money does FSD Pharma make?
One share of FSDDF stock can currently be purchased for approximately $0.84.
OTC Markets
FSD Pharma has a market capitalization of $6.37 million and generates $70 thousand in revenue each year.
Environmental, Social, and Governance Rating
FSD Pharma is a licensed medical cannabis producer in Canada. The company is in the process of converting a food facility formerly owned by Kraft Heinz to enable fully indoor cannabis production.
Business Summary
"A" score indicates excellent relative ESG performance and a high degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
